ENTIS associate members PhD candidate Laure Sillis and Dr Michael Ceulemans, alongside colleagues from KU Leuven, have published a study comparing self-reported maternal health and mother-infant outcomes in the BELpREG registry with medical record data from gynaecologists, general practitioners, and midwives. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis, Dr Essi Whaites Heinonen and Dr Michael Ceulemans, alongside OTIS colleagues from University of California San Diego La Jolla (California, USA), have published a study using the MotherToBaby cohort investigating the risk for adverse birth outcomes following maternal use of medicines for nausea and vomiting in pregnancy. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis and Dr Michael Ceulemans, alongside colleagues from KU Leuven, have published an updated summary of the medication, vaccine and folic acid use data from the the BELpREG Cohort. More information is available here.
» Read more
Researchers from the ENTIS member organisation Netherlands Pharmacovigilance Centre Lareb have published a comparative cohort study using the Dutch Pregnancy Drug Register to assess the risk of adverse neonatal outcomes following maternal pertussis vaccination in pregnancy. More information is available here. Photo by Alexander Grey on Unsplash
» Read more
An international collaboration of teratology researchers, several of whom are affiliated with ENTIS, have published an up-to-date meta-analysis exploring major congenital malformation risks following paternal exposure during spermatogenesis. More information is available here. Photo by Daniel Kraus on Unsplash
» Read more
Researchers from the teratology information service (TIS) at the Shamir Medical Center have published a comparative cohort study investigating the safety of maternal ondansetron use in pregnancy. More information is available here. Photo by Sasun Bughdaryan on Unsplash
» Read more
The ENTIS board would like to formally welcome our latest member organisation, the Norwegian RELIS Network and Safe Mother Medicine (Trygg Mammamedisin). Members of the network have been active associate members of ENTIS for several years, and it is fantastic to see the group become new full members within our network. We look forward to our continued collaboration. To find […]
» Read more
Prospective delegates are invited to submit research abstracts for the Annual ENTIS meeting which will be held in Leiden (NL) from the 3rd to 5th September. The abstract submission deadline is 31st March 2026. Authors will be notified of acceptance by 30th April 2026. Please see here for the abstract submission template and instructions for authors More information about the […]
» Read more
Researchers from Izmir TIS (Terafar), the Department of Medical Pharmacology, Marmara University School of Medicine, and the Turkish Medicines and Medical Devices Agency have published a systematic review and meta-analysis of pregnancy outcomes following paternal methotrexate exposure. More information is available here. Photo by Towfiqu barbhuiya, downloaded from Pexels.
» Read more
Professor Per Damkier (the outgoing Chair of the ENTIS Scientific Committee) and Dr Matitiahu Berkovitch (President of ENTIS) have published a commentary in the British Journal of Obstetrics and Gynaecology discussing the FDA panel discussion (broadcast 21 July 2025) about the safety of selective serotonin reuptake inhibitors (SSRI) in pregnancy. Photo by Sam Szuchan on Unsplash
» Read more